|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net loss | |||||
| Net loss from discontinued operations | |||||
| Net loss from continuing operations | |||||
| Adjustments to reconcile net loss from continuing operations to net cash provided by (used in) operating activities: | |||||
| Amortization of intangible assets | |||||
| Loss on disposal of property and equipment | |||||
| Amortization of operating lease right-of-use assets | |||||
| Income tax benefit | |||||
| Income tax benefit (liability) | |||||
| Depreciation of property and equipment | |||||
| Income tax liability | |||||
| Deferred tax liability | |||||
| Stock-based compensation | |||||
| Allowance for credit losses | |||||
| Changes in operating assets and liabilities, net of acquisition: | |||||
| Accounts receivable | |||||
| Operating lease liability | |||||
| Employee retention tax credit receivable, net | |||||
| Prepaid expense and other current assets | |||||
| Other assets | |||||
| Accounts payable, accrued expenses and other current liabilities, related party | |||||
| Deferred subscription revenue | |||||
| Net cash provided by (used in) operating activities – continuing operations | |||||
| Net cash used in operating activities –discontinued operations | |||||
| Net cash provided by (used in) operating activities | |||||
| Cash flows from investing activities: | |||||
| Payment of contingent consideration | |||||
| Cash paid for acquisition of NTS | |||||
| Purchases of fixed assets | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds from sale of Transferred Assets | |||||
| Purchase of treasury stock | |||||
| Proceeds from exercise of employee stock options | |||||
| Net cash provided by financing activities | |||||
| Net decrease in cash and cash equivalents | |||||
| Balance of cash and cash equivalents at beginning of year | |||||
| Balance of cash and cash equivalents and restricted cash and cash equivalents at end of year | |||||
| Supplemental non-cash disclosure: | |||||
| Non-cash portion of consideration for acquisition of NTS (Series A Preferred Stock issuance) | |||||
| Cash and cash equivalents | |||||
| Cash and cash equivalents (on deposit with related party) | |||||
| Cash and cash equivalents - restricted cash (on deposit with related party) | |||||
Loading...